» Articles » PMID: 35890385

Self-Emulsifying Drug Delivery Systems: An Alternative Approach to Improve Brain Bioavailability of Poorly Water-Soluble Drugs Through Intranasal Administration

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2022 Jul 27
PMID 35890385
Authors
Affiliations
Soon will be listed here.
Abstract

Efforts in discovering new and effective neurotherapeutics are made daily, although most fail to reach clinical trials. The main reason is their poor bioavailability, related to poor aqueous solubility, limited permeability through biological membranes, and the hepatic first-pass metabolism. Nevertheless, crossing the blood-brain barrier is the major drawback associated with brain drug delivery. To overcome it, intranasal administration has become more attractive, in some cases even surpassing the oral route. The unique anatomical features of the nasal cavity allow partial direct drug delivery to the brain, circumventing the blood-brain barrier. Systemic absorption through the nasal cavity also avoids the hepatic first-pass metabolism, increasing the systemic bioavailability of highly metabolized entities. Nevertheless, most neurotherapeutics present physicochemical characteristics that require them to be formulated in lipidic nanosystems as self-emulsifying drug delivery systems (SEDDS). These are isotropic mixtures of oils, surfactants, and co-surfactants that, after aqueous dilution, generate micro or nanoemulsions loading high concentrations of lipophilic drugs. SEDDS should overcome drug precipitation in absorption sites, increase their permeation through absorptive membranes, and enhance the stability of labile drugs against enzymatic activity. Thus, combining the advantages of SEDDS and those of the intranasal route for brain delivery, an increase in drugs' brain targeting and bioavailability could be expected. This review deeply characterizes SEDDS as a lipidic nanosystem, gathering important information regarding the mechanisms associated with the intranasal delivery of drugs loaded in SEDDS. In the end, in vivo results after SEDDS intranasal or oral administration are discussed, globally revealing their efficacy in comparison with common solutions or suspensions.

Citing Articles

Oral pH-Sensitive Solid Self-Microemulsion of Norcantharidin Wrapped in Colon-Coated Capsule for Selective Therapy of Colorectal Carcinoma.

Liu X, Fang W, Lu W, Xu M, Wu Z, Su D AAPS PharmSciTech. 2025; 26(3):67.

PMID: 39979516 DOI: 10.1208/s12249-025-03056-0.


Pharmacogenomics influence on MDR1-associated cancer resistance and innovative drug delivery approaches: advancing precision oncology.

Radhakrishnan A, Shanmukhan N, Samuel L Med Oncol. 2025; 42(3):67.

PMID: 39913003 DOI: 10.1007/s12032-025-02611-w.


Design and Evaluation of Clove Oil-Based Self-Emulsifying Drug Delivery Systems for Improving the Oral Bioavailability of Neratinib Maleate.

Mahajan R, Ravi P, Marathe R, Dongare A, Prabhu A, Szeleszczuk L Pharmaceutics. 2024; 16(8).

PMID: 39204432 PMC: 11358973. DOI: 10.3390/pharmaceutics16081087.


Development of a Versatile Nanostructured Lipid Carrier (NLC) Using Design of Experiments (DoE)-Part II: Incorporation and Stability of Butamben with Different Surfactants.

Matarazzo A, Rios C, Geronimo G, Ondei R, de Paula E, Breitkreitz M Pharmaceutics. 2024; 16(7).

PMID: 39065560 PMC: 11280378. DOI: 10.3390/pharmaceutics16070863.


Self-Nanoemulsion Intrigues the Gold Phytopharmaceutical Chrysin: In Vitro Assessment and Intrinsic Analgesic Effect.

Elhoseny S, Saleh N, Meshali M AAPS PharmSciTech. 2024; 25(3):54.

PMID: 38443653 DOI: 10.1208/s12249-024-02767-0.


References
1.
Wang H, Li L, Ye J, Dong W, Zhang X, Xu Y . Improved Safety and Anti-Glioblastoma Efficacy of CAT3-Encapsulated SMEDDS through Metabolism Modification. Molecules. 2021; 26(2). PMC: 7831126. DOI: 10.3390/molecules26020484. View

2.
Yu M, Yuan W, Li D, Schwendeman A, Schwendeman S . Predicting drug release kinetics from nanocarriers inside dialysis bags. J Control Release. 2019; 315:23-30. DOI: 10.1016/j.jconrel.2019.09.016. View

3.
Singh B, Bandopadhyay S, Kapil R, Singh R, Katare O . Self-emulsifying drug delivery systems (SEDDS): formulation development, characterization, and applications. Crit Rev Ther Drug Carrier Syst. 2010; 26(5):427-521. DOI: 10.1615/critrevtherdrugcarriersyst.v26.i5.10. View

4.
Srivastava R, Choudhury P, Dev S, Rathore V . Formulation and Evaluation of α-Pinene Loaded Self-emulsifying Nanoformulation for Anti-Parkinson's Activity. Recent Pat Nanotechnol. 2021; 16(2):139-159. DOI: 10.2174/1872210515666210329161439. View

5.
Buya A, Beloqui A, Memvanga P, Preat V . Self-Nano-Emulsifying Drug-Delivery Systems: From the Development to the Current Applications and Challenges in Oral Drug Delivery. Pharmaceutics. 2020; 12(12). PMC: 7764143. DOI: 10.3390/pharmaceutics12121194. View